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Introduction
Obesity is considered a worldwide public health crisis, leading to insulin resistance and cardiovascular disease (Weiss et al. 2004; Despres & Lemieux, 2006; Ritchie & Connell, 2007) . Altering the energy intake-and-expenditure balance in the body is one of the best strategies for obesity therapy (Crowley et al. 2002) . Adipose tissue is the body's largest energy reservoir (Frayn, 2002) , and also an endocrine organ (Kershaw & Flier, 2004) , which plays an important role in regulating energy homeostasis. Thus, increasing fat mobilization in adipose tissue is an attractive potential strategy for the management and treatment of obesity.
Fat mobilization from triglyceride stores in adipose tissue requires two major lipases: adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL; Zimmermann et al. 2004) . Adipose triglyceride lipase catalyses the initial step of triglyceride hydrolysis, whereas HSL is a rating-limiting enzyme responsible for hydrolysing diacylglycerol to monoacylglycerol. Activation of both enzymes corresponds to protein phosphorylation. Adipose triglyceride lipase is phosphorylated by AMPK to increase lipolysis and promotes mitochondrial fatty acid (FA) oxidation and uncoupling protein 1 induction for thermogenesis (Ahmadian et al. 2011) . Hormone-sensitive lipase phosphorylation depends on cAMP-dependent protein kinase (protein kinase A, PKA) activation, which depends on hormone interaction with G protein-coupled receptors (GPRs) that stimulates adenylate cyclase activity and increases cAMP levels (Yeaman, 1990) .
Butyrate is a short-chain fatty acid produced through fermentation of dietary fibres in the lower intestinal tract (Pryde et al. 2002) . Dietary supplementation of butyrate has been shown to prevent high-fat diet-induced obesity in mice (Gao et al. 2009 ) and in 3T3-L1 adipocytes (Rumberger et al. 2014) . In contrast, butyrate treatment attenuates lipolytic responses in rat primary adipocytes (Heimann et al. 2015) and in 3T3-L1 adipocytes co-cultured with macrophages (Ohira et al. 2013) . Therefore, how butyrate impacts lipids metabolism in adipose tissue is still controversial.
Moreover, butyrate is a histone deacetylase inhibitor, which improves high-fat diet-induced obesity, as well as insulin resistance in the liver and skeletal muscle through nucleosome remodelling in mice Henagan et al. 2015) . Also, as a ligand, butyrate binds to the GPR43 to exert physiological functions. Mice overexpressing GPR43 specifically in adipose tissues were lean in normal conditions (Kimura et al. 2013) . Similar to GPR43, β 3 -adrenergic receptors (ARβ3) also belong to the family of GPRs, which are largely expressed in adipose tissues to play important roles in lipolysis (Granneman et al. 2005) . β 3 -Adrenergic receptor agonist stimulates lipolysis by the activation of phosphorylation of HSL and perilipin A (Ahmadian et al. 2009; Granneman et al. 2009) . Although many publications have described that butyrate increases the number of β-adrenoceptors and the abundance of its transcript in Hela cells (Tallman et al. 1977) , hepatocytes (Lin et al. 1979) , smooth muscle cells (Nambi et al. 1986 ) and 3T3-L1 cells (Stadel et al. 1987) , it is still unclear how butyrate regulates ARβ3 and how it is involved in lipolysis in adipose tissue.
In this study, we aimed to investigate whether a short-term oral administration of sodium butyrate could stimulate lipolysis and mitochondrial function in adipose tissue, and how sodium butyrate regulates ARβ3 gene transcription through GPR43 activation and/or histone modification.
Methods

Ethical approval
All the procedures were approved by the Animal Ethics Committee of Nanjing Agricultural University, with the project number 2012CB124703. The killing and sampling procedures complied with the 'Guidelines on Ethical Treatment of Experimental Animals ' (2006) No. 398 set by the Ministry of Science and Technology, China.
Animal models and experimental protocols
Three-week-old male specific pathogen-free C57BL/6J mice (8-10 g) were obtained from the Comparative Medicine Center of Yangzhou University (Yangzhou, China; certificate of quality is SCXK (Su) 2012-0004) and kept in the Laboratory Animal Center of Jiangsu Province Integrative Medicine Hospital. The mice were housed in a controlled environment (22°C, 50-60% relative humidity) with a 12 h light-12 h dark cycle. They were allowed to adapt to their environment for 1 week. Next, the mice were randomly assigned to two groups; one group was fed a control diet (Con diet; 10% energy from fat) and the other was fed a high-fat diet (HF diet; 45% energy from fat) for 8 weeks to establish obesity. The nitritional contents of the 10 and 45% fat diets are listed in Table 1 . The mice were fed ad libitum with free access to water, and were weighed once per week. High-fat diet-induced obese mice maintained on the HF diet were divided into two subgroups; the HFB group was gavaged with 80 mg sodium butyrate (SB) in 1 ml deionized water per mouse every other day for 10 days, whereas the HF group received vehicle (deionized water). Two days after the fifth gavage, all the mice were fasted for 10 h before sampling. Mice were anaesthetized with an I.P. injection of pentobarbital sodium (80 mg kg −1 ), and blood was sampled from the abdominal aorta using a syringe with heparin (100 IU ml −1 ). Then the mice were killed by cervical dislocation.
The plasma was separated by centrifugation at 3000 g. for 15 min at 4°C and stored at −20°C. The epididymal fat was removed, weighed and snap-frozen in liquid nitrogen and then stored at −80°C.
Concentrations of biochemical parameters and hormones in plasma
The plasma concentration of non-esterified fatty acid (NEFA) was detected with an automatic biochemical analyser (Hitachi 7020; Hitachi, Tokyo, Japan) using commercial assay kits (995-09901; Wako Pure Chemical Industries, Wako, TX, USA). Plasma leptin concentrations were measured using a mouse leptin ELISA kit (EZML-82 K; Millipore, Darmstadt, Germany) according to the instructions provided by the manufacturer. 3) . B, body weight and epididymal fat weight (n = 10). C, plasma concentration of leptin and NEFA (n = 10). Abbreviations: Con, control diet; HF, high-fat diet; and HFB, high-fat diet gavaged with sodium butyrate. The results are expressed as means ± SD. Different letters indicate significant differences (P < 0.05).
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RNA isolation and quantitative real-time PCR
Total RNA was extracted from frozen adipose tissue samples (60 mg) using TRIzol reagent (15596026; Invitrogen, Waltham, MA, USA), and the RNA was reverse transcribed with the HiScript Reverse Transcriptase Kit (R123-01; Vazyme, Nanjing, China). Two microlitres of diluted cDNA (1:20) was used as a template in PCRs on a real-time PCR system (Mx3000P; Stratagene, La Jolla, CA, USA). PPIA was chosen as a reference gene. All primers were synthesized by Generay Biotech, Nanjing, China. The 2 − C T method was used to analyse real-time PCR data (Livak & Schmittgen, 2001 ).
Western blotting
Total protein was extracted from 80 mg frozen adipose tissue samples as previously described . 
Chromatin immunoprecipitation assay (ChIP)
The ChIP assay was performed according to a previous publication with some modifications (Haim et al. 2013) .
Approximately 500 mg samples of frozen adipose tissue were ground in liquid nitrogen and then resuspended in 1× PBS supplemented with a protease inhibitor cocktail (11697498001; Roche, Indianapolis, IN, USA).
Formaldehyde was added to a final concentration of 1% for cross-linking of protein and DNA, and then the reaction was stopped by adding glycine to a final concentration of 125 mmol l −1 . The reaction mix was centrifuged at 2500 g for 5 min, and the following three distinct phases could readily be visualized at this point: tissue aggregates of higher density (pellet, tissue debris); buffer containing the PBS, formaldehyde and glycine (intermediate liquid phase); and lipid-rich (low-density) tissue pieces and fat (upper layer). The upper layer was rinsed with ice-cold PBS and homogenized in an adipocyte lysis buffer containing protease inhibitors. Crude chromatin preparations were sonicated on ice to yield DNA fragments of 200-500 bp in length and were precleared with salmon sperm DNA-treated protein G agarose beads (40 μl, 50% slurry; sc-2003; Santa Cruz). The mixture of precleared chromatin preparations and 2 μg of H3 lysine 9 acetylation (H3K9Ac) antibody (ab4441; Abcam, Bristol, UK) was incubated overnight at 4°C. A negative control was included with normal IgG. Protein G agarose beads were added to capture the immunoprecipitated chromatin complexes. Finally, DNA fragments were extracted from the immunoprecipitated complexes and used as templates in quantitative real-time PCR to quantify the fragments of target gene promoters with specific primers.
Statistical analysis
All data are presented as mean values ± SD. One-way ANOVA with a Bonferroni post hoc test was used to evaluate the statistical significance of differences among three groups. A value of P < 0.05 was considered statistically significant.
Results
Sodium butyrate reduces body weight and decreases fat deposition
Sodium butyrate treatment significantly reduced body weight (P < 0.05; Fig. 1A and B) and decreased the size of the fat deposits (P < 0.05; Fig. 1A ) and adipose cells (P < 0.05; Fig. 1A ). The epididymal fat mass (P < 0.05; Fig. 1B ) was significantly reduced in the HFB group compared with the HF group. The concentration of plasma leptin (P < 0.05; Fig. 1C ) was significantly elevated in the HF group, which was completely restored to control (Acox1; n = 10) . B, the expression of mtDNA-encoded gene (n = 10). C and D, protein content of PGC-1α and COX4, respectively (n = 6). Abbreviations: Acox1, acyl-CoA oxidase 1; PGC-1α, peroxisome proliferator-activated receptor-γ coactivator 1α; PRDM16, PR domain containing 16; and UCP1, uncoupling protein 1. The results are expressed as means ± SD. Different letters indicate significant differences (P < 0.05).
Y. Jia and others levels by SB treatment. The concentrations of plasma NEFA (Fig. 1C) were not affected by high-fat diet or SB treatment.
Sodium butyrate increases protein content of AR3β and lipolytic enzymes
The protein contents of ARβ3 (P < 0.05; Fig. 2A ) and PKA (P < 0.05; Fig. 2A ) were significantly upregulated in the HFB group compared with the HF group. Accordingly, the reduction in epididymal fat mass in the HFB group was associated with significant upregulation of protein content for ATGL (P < 0.05; Fig. 2B ) and p-HSL (Ser563; P < 0.05; Fig. 2B ).
Sodium butyrate affects mitochondrial gene expression
Sodium butyrate treatment did not affect mRNA levels of UCP1, UCP3, PRDM16 or Acox1, but significantly increased PGC-1α at both mRNA (P < 0.05; Fig. 3A ) and protein levels (P < 0.05; Fig. 3C ). Also, mitochondrial oxidative phosphorylation genes were significantly upregulated in the HFB group compared with HF groups. Four mitochondrial DNA (mtDNA)-encoded genes, ND2, ND4, ND4L and COX1 (P < 0.05; Fig. 3B ), were significantly enhanced by SB treatment, whereas ND6, CYTB and ATP6 showed a tendency to increase. These changes were accompanied by higher COX4 protein content in the HFB group (P < 0.05; Fig. 3D ).
Sodium butyrate modifies histone acetylation on the promoter of the ARβ3 gene
The protein content of GPR43 (P < 0.05; Fig. 4A ) and p-CREB (Ser133; P < 0.05; Fig. 4A ) was significantly upregulated in the epididymal fat tissue of the HFB group, compared with the HF group. The ChIP analysis indicated that SB treatment significantly increased H3K9Ac recruitment onto the promoter of the ARβ3 gene (P < 0.05; Fig. 4C ), which was consistent with the activation of its gene transcription (P < 0.05; Fig. 4B ).
Discussion
There exists in the literature contradiction regarding the effects of butyrate on lipid metabolism in adipose tissues or adipocytes. In this study, we provide evidence that short-term oral administration (five gavage doses in 10 days) of SB is effective in the treatment of HF diet-induced obesity by promoting lipolysis in adipose tissue of mice. The epididymal fat mass and the size of adipocytes were significantly reduced after butyrate treatment, together with a significantly reduced plasma concentration of leptin. In other studies, the NEFA content in the plasma was increased, which resulted in upregulation of lipolysis in fat tissue (Canová et al. 2006; Roth Flach et al. 2013) . However, we observed no significant difference in plasma NEFA concentration between control and butyrate-treated groups. Given that the energy expenditure, fatty acid β-oxidation and mitochondrial function in skeletal muscle were all significantly increased after a short-term oral SB treatment in a HF diet-induced mouse model (Hong et al. 2016) , we speculate that most of the released fatty acids from adipose tissue may be transported to muscle for β-oxidation in skeletal muscle. Therefore, a cross-talk between adipose tissue and skeletal muscle plays an important role in the regulation of plasma NEFA homeostasis. The mechanism of action of butyrate in fat burning is related to stimulated lipolysis and enhanced mitochondrial function in brown fat tissue (Gao et al. 2009) . In this study, we focused on epididymal fat, which is white adipose tissue. We found that two lipases, ATGL and p-HSL, were significantly increased in the HFB group, which was associated with activation of AR3β and its downstream signalling molecule, PKA. It is reported that chronic treatment with ARβ3 agonist remodels white adipose tissue metabolism and induces mitochondrial electron transport activity (Granneman et al. 2003 (Granneman et al. ,2005 Mottillo et al. 2014) . In agreement with these findings, SB treatment significantly increased PGC-1α protein content and enhanced mitochondrial oxidative phosphorylation gene expression. Sodium butyrate is known as a histone deacetylase (HDAC) inhibitor and chromatin modifier, which has been shown to be effective in enhancing intestinal immunity (Chang et al. 2014) , alleviating diet-induced obesity (Gao et al. 2009 ) and improving neurological degenerative disorders (Yoo et al. 2015) . In this study, we found that H3K9Ac, a gene activation marker, was highly enriched on the promoter of the AR3β gene in the HFB group compared with the HF group. Butyrate-mediated activation of GPR43 is reported to suppress insulin-mediated fat accumulation in adipocytes (Kimura et al. 2013) . Our results indicate that SB administration induced GPR43 signalling and increased the protein content of p-CREB (Ser133), which is similar to a previous study (Le Poul et al. 2003) . Moreover, using a pattern-based program for predicting transcription factor binding sites (TRANSFAC R Public 6.0), three CREB binding sites are predicted on the promoter region (2000 bp upstream) of the AR3β gene. Owing to the limited amount of adipose samples, we did not have enough samples to carry out a ChIP assay for the validation of CREB binding sites. This merits future investigation of how histone acetylation interacts with CREB in AR3β gene transcriptional regulation when treated with butyrate.
In conclusion, our results suggest that SB treatment stimulates adipose lipolysis and mitochondrial oxidative phosphorylation through histone hyperacetylationassociated ARβ3 activation. A short-term oral administration of SB is beneficial for anti-obesity in mice, which may encourage potential application of butyrate and its derivatives in the treatment and prevention of obesity-related metabolic disorders in humans.
